Frontline treatment with chemoimmunotherapy for limited-stage ocular adnexal MALT lymphoma with adverse factors: a phase II study

about

Frontline treatment with chemoimmunotherapy for limited-stage ocular adnexal MALT lymphoma with adverse factors: a phase II study

Item

http://www.wikidata.org/entity/Q42366631

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Frontline treatment with chemo ...... erse factors: a phase II study

@en

Frontline treatment with chemo ...... erse factors: a phase II study

@nl

type

Item

label

Frontline treatment with chemo ...... erse factors: a phase II study

@en

Frontline treatment with chemo ...... erse factors: a phase II study

@nl

prefLabel

Frontline treatment with chemo ...... erse factors: a phase II study

@en

Frontline treatment with chemo ...... erse factors: a phase II study

@nl

P1476

Frontline treatment with chemo ...... erse factors: a phase II study

@en

P2093

Deok-Hwan Yang

http://www.w3.org/2001/XMLSchema#string

Hee Bae Ahn

http://www.w3.org/2001/XMLSchema#string

Hyo Jung Kim

http://www.w3.org/2001/XMLSchema#string

Jae Wook Yang

http://www.w3.org/2001/XMLSchema#string

Jee Ho Chang

http://www.w3.org/2001/XMLSchema#string

Min Joung Lee

http://www.w3.org/2001/XMLSchema#string

Seok-Goo Cho

http://www.w3.org/2001/XMLSchema#string

Seong Kyu Park

http://www.w3.org/2001/XMLSchema#string

Suk-Woo Yang

http://www.w3.org/2001/XMLSchema#string

Sung Yong Oh

http://www.w3.org/2001/XMLSchema#string

P2860

Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study

Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma)

The clinical characteristics and treatment results of ocular adnexal lymphoma

Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.

Extranodal marginal zone lymphoma of the ocular adnexa

A TNM-based clinical staging system of ocular adnexal lymphomas.

Outcomes of primary lymphoma of the ocular adnexa (orbital lymphoma) treated with radiotherapy.

Prognostic significance of anatomic subsites: results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma.

First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial.

Feasibility of the TNM-based staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).

P304

68583-68590

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19788

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28978139

http://www.w3.org/2001/XMLSchema#string

P932

5620279

http://www.w3.org/2001/XMLSchema#string